Puwainaphycin F
| Internal ID | 695c9e64-75ab-4143-b88b-6250015edd54 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides > Cyclic peptides |
| IUPAC Name | 2-[(3S,6R,9S,12S,15E,18S,21E,24S,31S)-3,18-bis(2-amino-2-oxoethyl)-28-dodecan-2-yl-15,21-di(ethylidene)-27-hydroxy-6-[(1S)-1-hydroxyethyl]-4,9-dimethyl-2,5,8,11,14,17,20,23,26,30-decaoxo-24-propan-2-yl-1,4,7,10,13,16,19,22,25,29-decazabicyclo[29.3.0]tetratriacontan-12-yl]acetamide |
| SMILES (Canonical) | CCCCCCCCCCC(C)C1C(C(=O)NC(C(=O)NC(=CC)C(=O)NC(C(=O)NC(=CC)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N2CCCC2C(=O)N1)CC(=O)N)C)C(C)O)C)CC(=O)N)CC(=O)N)C(C)C)O |
| SMILES (Isomeric) | CCCCCCCCCCC(C)C1C(C(=O)N[C@H](C(=O)N/C(=C/C)/C(=O)N[C@H](C(=O)N/C(=C/C)/C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N([C@H](C(=O)N2CCC[C@H]2C(=O)N1)CC(=O)N)C)[C@H](C)O)C)CC(=O)N)CC(=O)N)C(C)C)O |
| InChI | InChI=1S/C53H87N13O15/c1-10-13-14-15-16-17-18-19-21-28(6)41-43(71)51(79)62-40(27(4)5)50(78)59-32(12-3)46(74)61-34(25-38(55)69)48(76)58-31(11-2)45(73)60-33(24-37(54)68)47(75)57-29(7)44(72)64-42(30(8)67)53(81)65(9)36(26-39(56)70)52(80)66-23-20-22-35(66)49(77)63-41/h11-12,27-30,33-36,40-43,67,71H,10,13-26H2,1-9H3,(H2,54,68)(H2,55,69)(H2,56,70)(H,57,75)(H,58,76)(H,59,78)(H,60,73)(H,61,74)(H,62,79)(H,63,77)(H,64,72)/b31-11+,32-12+/t28?,29-,30-,33-,34-,35-,36-,40-,41?,42+,43?/m0/s1 |
| InChI Key | OGEPEQGQPSWALS-BMIHFYDPSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C53H87N13O15 |
| Molecular Weight | 1146.30 g/mol |
| Exact Mass | 1145.64445912 g/mol |
| Topological Polar Surface Area (TPSA) | 443.00 Ų |
| XlogP | 0.30 |
| Atomic LogP (AlogP) | -3.02 |
| H-Bond Acceptor | 15 |
| H-Bond Donor | 13 |
| Rotatable Bonds | 18 |
| DTXSID301047294 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6729 | 67.29% |
| Caco-2 | - | 0.8618 | 86.18% |
| Blood Brain Barrier | - | 0.8250 | 82.50% |
| Human oral bioavailability | - | 0.8429 | 84.29% |
| Subcellular localzation | Mitochondria | 0.5864 | 58.64% |
| OATP2B1 inhibitior | - | 0.8607 | 86.07% |
| OATP1B1 inhibitior | + | 0.8218 | 82.18% |
| OATP1B3 inhibitior | + | 0.8828 | 88.28% |
| MATE1 inhibitior | - | 0.9400 | 94.00% |
| OCT2 inhibitior | - | 0.8817 | 88.17% |
| BSEP inhibitior | + | 0.9000 | 90.00% |
| P-glycoprotein inhibitior | + | 0.7427 | 74.27% |
| P-glycoprotein substrate | + | 0.8808 | 88.08% |
| CYP3A4 substrate | + | 0.7190 | 71.90% |
| CYP2C9 substrate | - | 0.8019 | 80.19% |
| CYP2D6 substrate | - | 0.8681 | 86.81% |
| CYP3A4 inhibition | - | 0.9007 | 90.07% |
| CYP2C9 inhibition | - | 0.8760 | 87.60% |
| CYP2C19 inhibition | - | 0.8830 | 88.30% |
| CYP2D6 inhibition | - | 0.9347 | 93.47% |
| CYP1A2 inhibition | - | 0.8718 | 87.18% |
| CYP2C8 inhibition | + | 0.6457 | 64.57% |
| CYP inhibitory promiscuity | - | 0.9912 | 99.12% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.8800 | 88.00% |
| Carcinogenicity (trinary) | Non-required | 0.5515 | 55.15% |
| Eye corrosion | - | 0.9855 | 98.55% |
| Eye irritation | - | 0.8974 | 89.74% |
| Skin irritation | - | 0.7609 | 76.09% |
| Skin corrosion | - | 0.8998 | 89.98% |
| Ames mutagenesis | - | 0.7074 | 70.74% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6499 | 64.99% |
| Micronuclear | + | 0.7700 | 77.00% |
| Hepatotoxicity | + | 0.5033 | 50.33% |
| skin sensitisation | - | 0.8639 | 86.39% |
| Respiratory toxicity | + | 0.7556 | 75.56% |
| Reproductive toxicity | + | 0.8889 | 88.89% |
| Mitochondrial toxicity | + | 0.7625 | 76.25% |
| Nephrotoxicity | - | 0.6480 | 64.80% |
| Acute Oral Toxicity (c) | III | 0.6591 | 65.91% |
| Estrogen receptor binding | + | 0.7513 | 75.13% |
| Androgen receptor binding | + | 0.7236 | 72.36% |
| Thyroid receptor binding | + | 0.5327 | 53.27% |
| Glucocorticoid receptor binding | + | 0.5983 | 59.83% |
| Aromatase binding | + | 0.7239 | 72.39% |
| PPAR gamma | + | 0.7764 | 77.64% |
| Honey bee toxicity | - | 0.7939 | 79.39% |
| Biodegradation | - | 0.8000 | 80.00% |
| Crustacea aquatic toxicity | + | 0.5815 | 58.15% |
| Fish aquatic toxicity | + | 0.7030 | 70.30% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.72% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.34% | 96.09% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 97.48% | 90.08% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 96.43% | 97.25% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 95.73% | 92.86% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 95.21% | 93.00% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 95.13% | 96.47% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 94.99% | 90.71% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 94.57% | 82.38% |
| CHEMBL325 | Q13547 | Histone deacetylase 1 | 94.49% | 95.92% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 93.80% | 96.31% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 93.44% | 95.00% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 93.30% | 100.00% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 93.21% | 90.17% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 93.10% | 95.89% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 93.00% | 94.66% |
| CHEMBL1902 | P62942 | FK506-binding protein 1A | 92.89% | 97.05% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 92.63% | 94.45% |
| CHEMBL2443 | P49862 | Kallikrein 7 | 92.36% | 94.00% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 92.00% | 94.75% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 91.82% | 97.09% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 91.32% | 97.29% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 91.25% | 95.56% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 91.18% | 91.81% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 90.61% | 95.50% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 90.57% | 83.82% |
| CHEMBL299 | P17252 | Protein kinase C alpha | 90.43% | 98.03% |
| CHEMBL3837 | P07711 | Cathepsin L | 89.76% | 96.61% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 89.60% | 93.56% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 89.20% | 93.03% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 89.20% | 97.64% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 88.86% | 91.11% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 88.60% | 100.00% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 88.53% | 95.71% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 87.69% | 97.47% |
| CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 87.39% | 95.27% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 86.64% | 92.12% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 86.29% | 95.56% |
| CHEMBL1949 | P62937 | Cyclophilin A | 86.13% | 98.57% |
| CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 84.59% | 90.24% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 84.58% | 98.75% |
| CHEMBL3012 | Q13946 | Phosphodiesterase 7A | 84.55% | 99.29% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 84.46% | 85.14% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 84.14% | 98.33% |
| CHEMBL332 | P03956 | Matrix metalloproteinase-1 | 84.04% | 94.50% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 83.94% | 92.88% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 83.81% | 89.00% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 82.99% | 91.03% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 82.18% | 90.24% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 82.04% | 99.17% |
| CHEMBL4071 | P08311 | Cathepsin G | 81.21% | 94.64% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 81.12% | 100.00% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 81.07% | 97.50% |
| CHEMBL1994 | P08235 | Mineralocorticoid receptor | 81.00% | 100.00% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 80.57% | 96.90% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 80.17% | 99.18% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 146683704 |
| LOTUS | LTS0100135 |
| wikiData | Q104203068 |